Acyl Glucuronides Revisited: Is the Glucuronidation Proces a Toxification as Well as a Detoxification Mechanism?
|
journal
|
January 1992 |
Verification of protein structures: Patterns of nonbonded atomic interactions
|
journal
|
September 1993 |
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
|
journal
|
May 1997 |
WY 14,643 inhibits human aldose reductase activity
|
journal
|
January 2006 |
Molecular Mechanism of Peroxisome Proliferator-Activated Receptor α Activation by WY14643: a New Mode of Ligand Recognition and Receptor Stabilization
|
journal
|
August 2013 |
Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis: Steatohepatitis is attenuated by Wy14643
|
journal
|
January 2012 |
Biomolecular Chemistry of Isopropyl Fibrates
|
journal
|
April 2012 |
PROCHECK: a program to check the stereochemical quality of protein structures
|
journal
|
April 1993 |
The pp60 c-Src inhibitor PP1 is non-competitive against ATP
|
journal
|
January 2003 |
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
|
journal
|
February 2004 |
Mechanism of Aldose Reductase Inhibition: Binding of NADP+/NADPH and Alrestatin-like Inhibitors
|
journal
|
June 1994 |
Formation of Polyols by the Lens of the Rat with ‘Sugar’ Cataract
|
journal
|
July 1959 |
Le mécanisme de la formation du fructose séminal et du fructose foetal
|
journal
|
January 1960 |
Assessment of protein models with three-dimensional profiles
|
journal
|
March 1992 |
The involvement of aldose reductase in diabetic complications
|
journal
|
June 1988 |
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
|
journal
|
October 1990 |
The Mechanisms of Action of PPARs
|
journal
|
February 2002 |
A potent antihypercholesterolemic agent: [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14643)
|
journal
|
October 1974 |
An Evaluation of Charge Effects on the Quenching of Tryptophan Fluorescence in Small Peptides by Iodide ion
|
journal
|
July 1985 |
Fluorescence quenching and ligand binding: A critical discussion of a popular methodology
|
journal
|
July 2011 |
The Sorbitol Pathway and the Complications of Diabetes
|
journal
|
April 1973 |
Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy
|
journal
|
July 2001 |
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
|
journal
|
June 2003 |
A short history of SHELX
|
journal
|
December 2007 |
Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis
|
journal
|
January 1998 |
The Sorbinil Trap: A Predicted Dead-End Complex Confirms the Mechanism of Aldose Reductase Inhibition †
|
journal
|
August 2000 |
Protection against myocardial ischaemia/reperfusion injury by PPAR–α activation is related to production of nitric oxide and endothelin–1
|
journal
|
January 2006 |
Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus
|
journal
|
March 1999 |
Fluorescence Quenching to Study Protein-ligand Binding: Common Errors
|
journal
|
December 2009 |
STUDIES OF THE EFFICIENCY and MECHANISM OF FLUORESCENCE QUENCHING REACTIONS USING ACRYLAMIDE and SUCCINIMIDE AS QUENCHERS
|
journal
|
July 1987 |
Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat
|
journal
|
August 1977 |
Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers
|
journal
|
April 2008 |
Properties of Acyl Glucuronides: Implications for Studies of the Pharmacokinetics and Metabolism of Acidic Drugs
|
journal
|
January 1984 |
Structural and Functional Consequences of Mitochondrial Biogenesis in Human Adipocytes in Vitro
|
journal
|
December 2005 |
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|
journal
|
June 2003 |
Equilibrium binding of nicotinamide nucleotides to lactate dehydrogenases
|
journal
|
April 1973 |
Overview of the CCP4 suite and current developments.
|
text
|
January 2011 |
Fenofibric Acid.
|
journal
|
June 2005 |
A Study of the Interaction Between Malachite Green and Lysozyme by Steady-State Fluorescence
|
journal
|
March 2009 |
In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins
|
journal
|
September 1991 |
Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential
|
journal
|
December 1997 |
Crystal Structure of Hck in Complex with a Src Family–Selective Tyrosine Kinase Inhibitor
|
journal
|
May 1999 |
Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic Complications
|
journal
|
March 1987 |
Causation of Type 2 Diabetes — The Gordian Knot Unravels
|
journal
|
February 2004 |
The Role of Cys-298 in Aldose Reductase Function
|
journal
|
November 2010 |
Peroxisome Proliferator-activated Receptor (PPAR) Gene Profiling Uncovers Insulin-like Growth Factor-1 as a PPARα Target Gene in Cardioprotection
|
journal
|
January 2011 |
Catalytic Domain Crystal Structure of Protein Kinase C-θ (PKCθ)
|
journal
|
September 2004 |
Fenofibric acid
|
journal
|
January 2005 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
Data processing and analysis with the autoPROC toolbox
|
journal
|
March 2011 |
How good are my data and what is the resolution?
|
journal
|
June 2013 |
2.2 Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor
|
journal
|
May 1993 |
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
|
journal
|
June 2003 |
Chemistory of Fibrates
|
journal
|
September 2007 |